正在加载公司
Keep exploring
The themes Johnson & Johnson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
- 精选
Medical devices
由 InspectStocks 整理 · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
- 股价，1 年
- +6.2%
- 营收，1 年
- +7.2%
+14A 8B 7C 3D 2
- 精选
Big pharma
由 InspectStocks 整理 · 13 companies
The largest drugmakers, selling prescription medicines worldwide.
- 股价，1 年
- +41.6%
- 营收，1 年
- +10.8%
+7A 7B 3C 3
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
- LLYELI Lilly And CompanyUS$1.36TA+
- MRKMerck & Co., Inc.US$364.3BA
- NVSNovartis AGUS$306.3BA
AMGNAmgen Inc.US$251.9BA+
GILDGilead Sciences, Inc.US$208.4BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
GEHCGE Healthcare Technologies Inc.2026年10月28日CAGraded C, now A
怎么赚钱
- Innovative Medicine64%
- MedTech36%
各项收入占比是对six months ended June 28, 2026, high confidence的估算，并非来自已提交报告的数字。
竞争对手
卖什么6
DARZALEX
A medicine used to treat multiple myeloma, a cancer of plasma cells.
TREMFYA
A medicine for conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
CARVYKTI
A treatment made from a patient’s modified immune cells for multiple myeloma that has returned or has not responded to earlier treatment.
再显示 3 项
VARIPULSE
A system that uses pulsed electrical energy to treat atrial fibrillation, a disorder that causes an irregular heartbeat.
Impella
A heart pump used to support blood circulation in certain patients with heart failure or during high-risk heart procedures.
ACUVUE
A brand of contact lenses sold for vision correction.
谁在买4
- Wholesalers, distributors and retailers that buy medicines and medical products for resale.
- Hospitals and clinics that buy medicines and devices for patient care and procedures.
- Physicians and other healthcare professionals who prescribe medicines or use medical devices in treatment.
- Eye-care professionals and retailers that supply contact lenses and other vision products.
靠什么支撑，什么会击垮它
业务依赖什么
- 1Some medicines rely on licenses or partnerships with other companies. For example, a subsidiary licenses patent families related to DARZALEX from Genmab, and IMBRUVICA is co-commercialized in the United States with Pharmacyclics, an AbbVie company.
- 2The company depends on government approvals and ongoing oversight for its medicines and medical devices, including rules on safety, manufacturing, labeling and sales.
- 3Sales depend partly on health insurers and government programs deciding whether to cover products and how much they will reimburse; U.S. and other governments can also change medicine-pricing rules.
- 4The company uses third parties to make or supply some products and relies on complex international manufacturing and distribution chains.
可能出什么问题
- 1Generic and biosimilar competition can reduce sales of medicines when alternatives enter the market. The latest quarterly report describes continuing sales declines for STELARA and says biosimilar competition is also affecting other medicines.
- 2Government pricing rules, coverage decisions and reimbursement changes can affect what the company receives for medicines and medical devices. The company identifies U.S. drug-pricing measures and tighter regulation across markets as concerns.
- 3Lawsuits and product-safety claims can lead to substantial costs and affect sales or reputation. The latest quarterly report recorded charges related to talc litigation.
关于Johnson & Johnson
Johnson & Johnson develops, makes and sells prescription medicines and medical devices around the world. Its two businesses are Innovative Medicine, which sells medicines for conditions including cancer and immune disorders, and MedTech, which sells products used in heart procedures, surgery, orthopaedics and vision care.
- 总部
- New Brunswick, New Jersey
- 成立于
- 1887 (founding year, high confidence)
- 员工人数
- 140,800 (December 28, 2025, high confidence)
- 上市于
- New York Stock Exchange
- 财年结束
- Last Sunday in December
基于 Johnson & Johnson 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。